Construction of recombinant BCGs overexpressing antigen 85 complex and their protective efficacy against Mycobacterium tuberculosis infection in a mouse model

Seung Heon Lee, Bo Young Jeon, Young Gil Park, Hyeyoung Lee, Sangnae Cho, Hyo Joon Kim, Gill Han Bai

Research output: Contribution to journalArticle

Abstract

Tuberculosis (TB) remains an enormous global health problem, and a new vaccine against TB more potent than the current inadequate BCG vaccine is urgently needed. We constructed three recombinant Mycobacterium bovis BCG (rBCG) strains over-expressing antigen (Ag) 85A, Ag85B, or both of M. tuberculosis using their own promoter and secretory sequence, or hsp60 promoter. SDS-PAGE analysis of rBCG proteins showed overexpression of Ag85A and Ag85B proteins in higher level than of those in their parental strain of BCG. In addition, rBCG(rBCG/B.FA) over-expressing Ag85A and Ag85B induced strong IFN- γ production in splenocytes. However, there was no significant difference in protective efficacy between rBCG and their parental BCG strain. In this study, therefore, rBCG over-expressing Ag85A, Ag85B, or both failed to show enhanced protection against M. tuberculosis infection in a mouse model.

Original languageEnglish
Pages (from-to)125-131
Number of pages7
JournalTuberculosis and Respiratory Diseases
Volume57
Issue number2
Publication statusPublished - 2004 Aug 1

Fingerprint

Mycobacterium Infections
Mycobacterium bovis
Mycobacterium tuberculosis
Tuberculosis Vaccines
BCG Vaccine
Polyacrylamide Gel Electrophoresis
Tuberculosis
Proteins
Antigens
Mycobacterium bovis antigen 85

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

@article{08c8dc957b8c41d18ce742e9be7cddeb,
title = "Construction of recombinant BCGs overexpressing antigen 85 complex and their protective efficacy against Mycobacterium tuberculosis infection in a mouse model",
abstract = "Tuberculosis (TB) remains an enormous global health problem, and a new vaccine against TB more potent than the current inadequate BCG vaccine is urgently needed. We constructed three recombinant Mycobacterium bovis BCG (rBCG) strains over-expressing antigen (Ag) 85A, Ag85B, or both of M. tuberculosis using their own promoter and secretory sequence, or hsp60 promoter. SDS-PAGE analysis of rBCG proteins showed overexpression of Ag85A and Ag85B proteins in higher level than of those in their parental strain of BCG. In addition, rBCG(rBCG/B.FA) over-expressing Ag85A and Ag85B induced strong IFN- γ production in splenocytes. However, there was no significant difference in protective efficacy between rBCG and their parental BCG strain. In this study, therefore, rBCG over-expressing Ag85A, Ag85B, or both failed to show enhanced protection against M. tuberculosis infection in a mouse model.",
author = "Lee, {Seung Heon} and Jeon, {Bo Young} and Park, {Young Gil} and Hyeyoung Lee and Sangnae Cho and Kim, {Hyo Joon} and Bai, {Gill Han}",
year = "2004",
month = "8",
day = "1",
language = "English",
volume = "57",
pages = "125--131",
journal = "Tuberculosis and Respiratory Diseases",
issn = "1738-3536",
publisher = "The Korean Academy of Tuberculosis and Respiratory Diseases",
number = "2",

}

Construction of recombinant BCGs overexpressing antigen 85 complex and their protective efficacy against Mycobacterium tuberculosis infection in a mouse model. / Lee, Seung Heon; Jeon, Bo Young; Park, Young Gil; Lee, Hyeyoung; Cho, Sangnae; Kim, Hyo Joon; Bai, Gill Han.

In: Tuberculosis and Respiratory Diseases, Vol. 57, No. 2, 01.08.2004, p. 125-131.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Construction of recombinant BCGs overexpressing antigen 85 complex and their protective efficacy against Mycobacterium tuberculosis infection in a mouse model

AU - Lee, Seung Heon

AU - Jeon, Bo Young

AU - Park, Young Gil

AU - Lee, Hyeyoung

AU - Cho, Sangnae

AU - Kim, Hyo Joon

AU - Bai, Gill Han

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Tuberculosis (TB) remains an enormous global health problem, and a new vaccine against TB more potent than the current inadequate BCG vaccine is urgently needed. We constructed three recombinant Mycobacterium bovis BCG (rBCG) strains over-expressing antigen (Ag) 85A, Ag85B, or both of M. tuberculosis using their own promoter and secretory sequence, or hsp60 promoter. SDS-PAGE analysis of rBCG proteins showed overexpression of Ag85A and Ag85B proteins in higher level than of those in their parental strain of BCG. In addition, rBCG(rBCG/B.FA) over-expressing Ag85A and Ag85B induced strong IFN- γ production in splenocytes. However, there was no significant difference in protective efficacy between rBCG and their parental BCG strain. In this study, therefore, rBCG over-expressing Ag85A, Ag85B, or both failed to show enhanced protection against M. tuberculosis infection in a mouse model.

AB - Tuberculosis (TB) remains an enormous global health problem, and a new vaccine against TB more potent than the current inadequate BCG vaccine is urgently needed. We constructed three recombinant Mycobacterium bovis BCG (rBCG) strains over-expressing antigen (Ag) 85A, Ag85B, or both of M. tuberculosis using their own promoter and secretory sequence, or hsp60 promoter. SDS-PAGE analysis of rBCG proteins showed overexpression of Ag85A and Ag85B proteins in higher level than of those in their parental strain of BCG. In addition, rBCG(rBCG/B.FA) over-expressing Ag85A and Ag85B induced strong IFN- γ production in splenocytes. However, there was no significant difference in protective efficacy between rBCG and their parental BCG strain. In this study, therefore, rBCG over-expressing Ag85A, Ag85B, or both failed to show enhanced protection against M. tuberculosis infection in a mouse model.

UR - http://www.scopus.com/inward/record.url?scp=7644240201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7644240201&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 125

EP - 131

JO - Tuberculosis and Respiratory Diseases

JF - Tuberculosis and Respiratory Diseases

SN - 1738-3536

IS - 2

ER -